06.06.2013 Views

Donepezil, rivastigmine, galantamine and memantine for ...

Donepezil, rivastigmine, galantamine and memantine for ...

Donepezil, rivastigmine, galantamine and memantine for ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Supporting data on the weekly cost of care homes<br />

are available from the website bettercaring.co.uk,<br />

with estimates based on a sample of UK regions.<br />

Private care homes are reported to have a mean<br />

weekly cost of £280 (range £248–326) <strong>and</strong><br />

voluntary care homes £303 per week (range<br />

£253–361). Private care homes with nursing had a<br />

mean weekly cost of £370 (range £318–481) <strong>and</strong><br />

voluntary care homes with nursing £385 (range<br />

£313–473). These data show a range of annual<br />

costs between £14,584 <strong>and</strong> £20,039.<br />

Netten <strong>and</strong> colleagues present in<strong>for</strong>mation on the<br />

breakdown of people who were publicly <strong>and</strong><br />

privately funded in residential care. In the<br />

permanent stay category there were 8194 residents<br />

classed as publicly funded with 3155 classed as<br />

privately funded. There were similar proportions<br />

of patients in these funding categories that were<br />

classed as severely cognitively impaired, 29 <strong>and</strong><br />

27%, respectively. This indicates that in the<br />

severely impaired group around 35% of people are<br />

privately funded. This may be an important factor,<br />

as it shows that not all residential care <strong>for</strong> severely<br />

affected AD patients will be the responsibility of<br />

the NHS <strong>and</strong> PSS budget. Netten <strong>and</strong> colleagues<br />

also present findings to show that there is a similar<br />

distribution of setting of residential care <strong>for</strong><br />

publicly <strong>and</strong> privately funded persons (e.g. 44% of<br />

publicly funded <strong>and</strong> 38% of privately funded<br />

persons are expected to be in nursing homes),<br />

although the latter group are less likely to be<br />

residents in a local authority home.<br />

Health Technology Assessment 2006; Vol. 10: No. 1<br />

TABLE 62 Weekly prices (£) charged <strong>for</strong> residential care in Engl<strong>and</strong> (1998–99 prices), reported by Netten <strong>and</strong> colleagues 130<br />

© Queen’s Printer <strong>and</strong> Controller of HMSO 2006. All rights reserved.<br />

Private Voluntary Dual-registered Nursing homes<br />

residential residential homes<br />

homes homes<br />

All residents 247 259 322 349<br />

Severely cognitively impaired residents 248 274 333 344<br />

TABLE 63 Direct <strong>and</strong> indirect 3-month costs (£) of controls <strong>and</strong> patients with AD (non-institutionalised)<br />

Costs Controls Mild AD Moderate AD Severe AD<br />

(n = 38) (n = 42) (n = 48)<br />

Direct medical costs 199 1,220 3,165 3,387<br />

Total direct non-medical costs 188 474 636 902<br />

Indirect costs – 4,922 6,449 9,304<br />

Total cost 387 6,616 10,250 13,593<br />

Costs in 1993 UK£. Costs not all related to AD.<br />

Source: Data presented by Souêtre <strong>and</strong> colleagues. 158<br />

Souêtre <strong>and</strong> colleagues 158 present findings from a<br />

UK cross-sectional multicentre study examining<br />

costs associated with different severities of AD, in<br />

non-institutionalised patients (n = 128), <strong>and</strong><br />

matched controls (n = 56). Data were collected by<br />

interview (during 1994), across patients stratified<br />

by MMSE score into mild AD (score >18),<br />

moderate AD (score 10–18) <strong>and</strong> severe AD (score<br />

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!